3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Smoking
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Hyperlipoproteinemia Type II
1
Hematologic Neoplasms
1
Hearing Loss
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Advanced Renal Cell Carcinoma (RCC)
1
Interventions
Rituximab
27
acalabrutinib
15
ibrutinib
13
Cyclophosphamide
12
Lenalidomide
10
CT-P10
10
zanubrutinib
9
venetoclax
9
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
Specimen Handling
7
Cytarabine
7
Bendamustine Hydrochloride
7
pirtobrutinib
6
fludarabine
6
Biopsy
6
glofitamab
5
fludarabine phosphate
5
Peripheral Blood Stem Cell Transplantation
5
Cyclosporine
5
brexucabtagene autoleucel
4
Whole-Body Irradiation
4
Mycophenolic Acid
4
Vincristine
3
Stem Cell Transplantation
3
Sirolimus
3
Methotrexate
3
Etoposide
3
Doxorubicin
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Atorvastatin
×
90 days
×
Clear all
No trials found.